Latest news
Find out more about our work by reading our latest press releases, statements and insight articles.
For media enquiries, please contact Rob Kelly, Head of External Relations.
Email Rob
Featured article
28 November 2022
Five key lessons from our first five years
MedAccess colleagues share five key learnings from our first five years about using innovative finance to increase access to healthcare. We’ve learned a lot in our first five years. When MedAccess was formed in 2017, we knew that financial guarantees could accelerate access to medical innovations for millions of people.…
Read more
1 October 2022
Professor Helen Rees appointed MedAccess Board Chair
MedAccess is pleased to announce the appointment of Professor Helen Rees OBE as the new Chair of the Board of…
21 September 2022
MedAccess expects to deploy more than $150 million to support Global Fund’s fight against HIV, TB and malaria
MedAccess CEO Michael Anderson announced the social finance company’s intention at an event hosted in New York ahead of the…
8 September 2022
P. vivax malaria elimination efforts boosted by new agreement to expand access to G6PD testing
MedAccess, PATH, and SD Biosensor today announced a new partnership aimed at advancing progress towards elimination of P. vivax malaria.…
2 August 2022
The reality of undiagnosed syphilis for mothers and babies
Nigeria is ramping up the use of a test which can detect both HIV and syphilis simultaneously. But why is…
1 August 2022
Partners announce reduced price for patient-friendly tuberculosis preventive treatments
New lower prices negotiated as partners aim to increase access to short-course tuberculosis preventive treatments. Unitaid, The Aurum Institute, the…
31 July 2022
5 things you should know about HIV self-testing
CHAI spoke with HIV advocate and Director of the African Community Advisory Board (AfroCAB) Treatment Access Partnership Kenly Sikwese about…
28 July 2022
AVAC, BMGF, CIFF, MedAccess, Unitaid, and ViiV Healthcare announce collaboration to catalyse more affordable access to long-acting injectable cabotegravir for HIV prevention
MedAccess joins partners to speed up equitable access to injectable cabotegravir for HIV pre-exposure prophylaxis (PrEP). At the 24th International…
27 July 2022
New agreement secures historic US$1 price for HIV self-test
MedAccess, the Clinton Health Access Initiative (CHAI), and Wondfo announced an agreement to make Wondfo’s HIV self-test available for US$1.…
30 June 2022
2021 Annual Review: Accelerating impact and preparing for the future
MedAccess today publishes its 2021 Annual Review, setting out how our guarantees helped accelerate access to vital healthcare products in…
